We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBM icon
3376
Hudbay
HBM
$11.9B
$39K ﹤0.01%
9,611
-1,751
-15% -$7.01K
IMRX icon
3377
Immuneering
IMRX
$327M
$39K ﹤0.01%
2,717
-111
-4% -$881
KNSA icon
3378
Kiniksa Pharmaceuticals
KNSA
$5.99B
$39K ﹤0.01%
3,077
-1,203
-28% -$13.7K
KRNT icon
3379
Kornit Digital
KRNT
$775M
$39K ﹤0.01%
+1,480
New +$42.6K
ONL
3380
Orion Office REIT
ONL
$164M
$39K ﹤0.01%
4,513
-8,983
-67% -$92.1K
PAYS icon
3381
Paysign
PAYS
$744M
$39K ﹤0.01%
16,382
+12,086
+281% +$28.9K
PLYM
3382
DELISTED
Plymouth Industrial REIT
PLYM
$39K ﹤0.01%
2,337
+989
+73% +$19.2K
PRAX icon
3383
Praxis Precision Medicines
PRAX
$10.2B
$39K ﹤0.01%
1,136
+211
+23% +$10.5K
RIGL icon
3384
Rigel Pharmaceuticals
RIGL
$795M
$39K ﹤0.01%
3,288
-7,706
-70% -$104K
RYAAY icon
3385
Ryanair
RYAAY
$30.5B
$39K ﹤0.01%
1,683
-7,577
-82% -$213K
TASK icon
3386
TaskUs
TASK
$688M
$39K ﹤0.01%
2,410
-344
-12% -$6.07K
TERN
3387
DELISTED
Terns Pharmaceuticals
TERN
$39K ﹤0.01%
6,601
-3,879
-37% -$14.4K
THRY icon
3388
Thryv Holdings
THRY
$96M
$39K ﹤0.01%
1,707
-638
-27% -$15.9K
UHT
3389
Universal Health Realty Income Trust
UHT
$574M
$39K ﹤0.01%
910
-2,399
-72% -$122K
QVCGB
3390
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$39K ﹤0.01%
+116
New +$49.6K
SURF
3391
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$39K ﹤0.01%
37,300
+32,306
+647% +$51.6K
DZSI
3392
DELISTED
DZS Inc. Common Stock
DZSI
$39K ﹤0.01%
3,418
+2,893
+551% +$41K
ACCO icon
3393
Acco Brands
ACCO
$401M
$38K ﹤0.01%
7,798
+4,197
+117% +$26.6K
AGYS icon
3394
Agilysys
AGYS
$3.22B
$38K ﹤0.01%
689
-103
-13% -$5.19K
ANIK icon
3395
Anika Therapeutics
ANIK
$288M
$38K ﹤0.01%
1,601
+608
+61% +$14K
BFST icon
3396
Business First Bancshares
BFST
$1.05B
$38K ﹤0.01%
1,778
+88
+5% +$2.01K
BRFS
3397
DELISTED
BRF SA
BRFS
$38K ﹤0.01%
16,636
+6,509
+64% +$19.2K
ERAS icon
3398
Erasca
ERAS
$6.43B
$38K ﹤0.01%
4,910
-1,039
-17% -$8.37K
ETD icon
3399
Ethan Allen Interiors
ETD
$581M
$38K ﹤0.01%
1,783
+553
+45% +$12.9K
FXNC icon
3400
First National Corp
FXNC
$288M
$38K ﹤0.01%
2,522
+1,885
+296% +$32.4K
134 135
136
137 138

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.